tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
Holding GYRE?
Track your performance easily

Gyre Therapeutics (GYRE) Income Statement

799 Followers

Gyre Therapeutics Income Statement

Last quarter (Q3 2024), Gyre Therapeutics's total revenue was $25.49M, a decrease of -13.10% from the same quarter last year. In Q3, Gyre Therapeutics's net income was $1.12M. See Gyre Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 77.89M$ 113.45M$ 794.00K$ 7.34M$ 20.95M-
Cost of Revenue
$ 2.71M$ 4.64M$ 798.00K$ 4.02M$ 6.06M-
Gross Profit
$ 75.18M$ 108.81M$ -4.00K$ 85.57M$ 14.89M-
Operating Expense
$ 61.23M$ 89.60M$ -65.79M$ 95.23M$ 78.32M$ -57.28M
Operating Income
$ 13.94M$ -67.23M$ -65.80M$ -87.89M$ -57.37M$ -57.28M
Net Non Operating Interest Income Expense
$ 1.20M$ 1.04M$ 537.00K$ 39.00K$ 561.00K$ 2.15M
Other Income Expense
$ -5.68M$ -97.22M$ -57.19M$ 78.00K$ 91.00K$ -7.00K
Pretax Income
$ 20.87M$ -76.97M$ -7.89M$ -87.93M$ -57.37M$ -57.28M
Tax Provision
$ 5.12M$ 8.52M$ 348.00K$ 6.17M--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 10.61M$ -92.93M$ -8.24M$ 23.44M$ -56.24M$ -55.18M
Basic EPS
$ 0.10$ -1.41$ -0.26$ -43.05$ -43.95-
Diluted EPS
$ 0.01$ -1.41$ -0.26$ -43.05$ -43.95$ -69.00
Basic Average Shares
$ 292.39M$ 65.83M$ 31.55M$ 2.04M$ 1.28M$ 800.30K
Diluted Average Shares
$ 347.54M$ 65.83M$ 31.55M$ 2.04M$ 1.28M$ 799.68K
Dividend Per Share
--$ 0.24---
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 63.94M$ 94.24M$ 10.20M$ 102.61M$ 84.38M$ -57.28M
Net Income From Continuing And Discontinued Operation
$ 10.61M$ -92.93M$ -8.24M$ 23.44M$ -56.24M$ -55.18M
Normalized Income
$ 21.04M-$ -62.41M$ -65.30M--
Interest Expense
------
EBIT
$ 19.67M$ -78.01M$ -7.89M$ 29.73M$ -57.37M$ -57.28M
EBITDA
$ 20.79M$ -76.89M$ -7.66M$ 31.66M$ -57.23M$ -57.13M
Currency in USD

Gyre Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis